China Medical & HealthCare Group Limited (COLRF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
China Medical & HealthCare Group Limited (COLRF) with AI Score 48/100 (Weak). China Medical & HealthCare Group Limited operates hospitals and related healthcare services across China, Australia, and the Philippines. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026China Medical & HealthCare Group Limited (COLRF) Healthcare & Pipeline Overview
China Medical & HealthCare Group Limited, an investment holding company, operates hospitals and eldercare facilities across China, Australia, and the Philippines. With diversified operations in property development, financial services, and securities trading, the company caters to a broad healthcare and retirement market, demonstrating a modest profit margin and a notable dividend yield.
Investment Thesis
China Medical & HealthCare Group Limited presents a diversified investment profile with its involvement in healthcare, eldercare, property development, and financial services. The company's operations across China, Australia, and the Philippines provide geographic diversification. With a market capitalization of $0.12 billion and a P/E ratio of 53.94, the company's valuation reflects its growth potential and current profitability. The dividend yield of 3.16% offers an income component to investors. Key growth catalysts include the increasing demand for healthcare and eldercare services in its operating regions. Potential risks include the relatively low profit margin of 1.2% and the challenges associated with operating in multiple regulatory environments. The company's beta of 0.56 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.12 billion indicates the company's size and market value.
- P/E ratio of 53.94 reflects investor expectations for future earnings growth.
- Profit margin of 1.2% suggests potential areas for operational efficiency improvements.
- Gross margin of 18.9% indicates the profitability of the company's core operations.
- Dividend yield of 3.16% provides an income stream for investors.
Competitors & Peers
Strengths
- Diversified operations across healthcare, eldercare, property development, and financial services.
- Geographic presence in China, Australia, and the Philippines.
- Integrated business model with synergies between different segments.
- Experience in developing and managing health campuses for elderly care.
Weaknesses
- Relatively low profit margin of 1.2%.
- Exposure to multiple regulatory environments.
- Limited brand recognition compared to larger healthcare providers.
- Dependence on economic conditions in its operating regions.
Catalysts
- Ongoing: Expansion of eldercare facilities to meet the growing demand from the aging population.
- Ongoing: Development of new health campuses with integrated healthcare services.
- Upcoming: Potential acquisitions of other healthcare providers or related businesses.
- Ongoing: Investment in medical technology to enhance service quality and attract more patients.
Risks
- Ongoing: Intense competition from other healthcare providers and real estate developers.
- Potential: Changes in healthcare regulations and reimbursement policies.
- Potential: Economic downturns that could reduce demand for healthcare services and property.
- Ongoing: Fluctuations in currency exchange rates.
- Potential: Limited liquidity and price volatility due to OTC trading.
Growth Opportunities
- Expansion of Eldercare Facilities: The increasing aging population in China and other regions presents a significant growth opportunity for China Medical & HealthCare Group Limited's eldercare segment. The company can expand its network of elderly nursing homes, service apartments, and independent living units to cater to this growing demand. The global eldercare market is projected to reach trillions of dollars in the coming years, offering substantial revenue potential. Timeline: Ongoing.
- Geographic Expansion: China Medical & HealthCare Group Limited can explore opportunities to expand its operations into new geographic markets, particularly in Southeast Asia and other regions with growing demand for healthcare and eldercare services. This expansion can be achieved through acquisitions, partnerships, or greenfield developments. The timeline for geographic expansion will depend on regulatory approvals and market conditions. Timeline: Upcoming.
- Development of Integrated Healthcare Campuses: The company's expertise in developing health campuses with a focus on elderly care and retirement communities provides a unique competitive advantage. China Medical & HealthCare Group Limited can leverage this expertise to develop more integrated healthcare campuses that offer a comprehensive range of services, including medical care, rehabilitation, and assisted living. Timeline: Ongoing.
- Investment in Medical Technology: China Medical & HealthCare Group Limited can invest in advanced medical technology and equipment to enhance the quality of its healthcare services and attract more patients. This includes investing in telemedicine, remote monitoring, and other digital health solutions. The global market for medical technology is growing rapidly, driven by advancements in technology and increasing demand for healthcare services. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: The company can pursue strategic partnerships and acquisitions to expand its service offerings, geographic reach, and market share. This includes partnering with other healthcare providers, technology companies, and real estate developers. Strategic partnerships and acquisitions can accelerate growth and create synergies. Timeline: Ongoing.
Opportunities
- Expansion of eldercare facilities to cater to the aging population.
- Geographic expansion into new markets with growing demand for healthcare services.
- Development of integrated healthcare campuses with a comprehensive range of services.
- Investment in medical technology to enhance the quality of its healthcare services.
Threats
- Intense competition from other healthcare providers and real estate developers.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns that could reduce demand for healthcare services and property.
- Fluctuations in currency exchange rates.
Competitive Advantages
- Geographic diversification across China, Australia, and the Philippines.
- Integrated business model combining healthcare, eldercare, and property development.
- Expertise in developing and managing health campuses for elderly care.
- Established presence in the healthcare and real estate sectors.
About COLRF
China Medical & HealthCare Group Limited was incorporated in 1990 and initially operated under the name COL Capital Limited before rebranding in February 2016 to reflect its strategic focus on the healthcare sector. Headquartered in Wanchai, Hong Kong, the company has evolved into an investment holding entity with a significant presence in the healthcare industry across multiple geographies, including the People's Republic of China, Australia, and the Philippines. The company's operations are segmented into six key areas: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. This diversification allows China Medical & HealthCare Group Limited to capture value across different stages of the healthcare and real estate value chains. Its healthcare segment focuses on operating hospitals and providing medical services, while the eldercare segment caters to the growing demand for elderly care facilities and services. The company is also involved in property development, focusing on independent living units and health campuses designed for elderly care and retirement communities. These campuses include nursing homes, service apartments, independent living units, shopping malls, retail shops, and club hall facilities, creating comprehensive retirement ecosystems. Beyond healthcare and real estate, China Medical & HealthCare Group Limited also engages in financial services, including money lending, and securities trading and investments, further diversifying its revenue streams. Additionally, the company trades medical equipment and related supplies, complementing its healthcare operations.
What They Do
- Operates hospitals in China, Australia, and the Philippines.
- Develops and manages eldercare facilities, including nursing homes and service apartments.
- Engages in property development of independent living units and health campuses.
- Provides financial services, including money lending.
- Trades medical equipment and related supplies.
- Invests in securities listed on overseas exchanges.
Business Model
- Generates revenue from hospital operations and medical services.
- Earns income from the development and sale of properties.
- Collects rental income from leasing residential and office properties.
- Derives revenue from financial services, including interest income from lending.
Industry Context
China Medical & HealthCare Group Limited operates within the healthcare and real estate sectors, both of which are experiencing growth driven by demographic shifts and increasing demand for healthcare services and retirement living. The global healthcare market is projected to continue expanding, fueled by aging populations and advancements in medical technology. The company's focus on eldercare aligns with the increasing demand for specialized facilities and services for seniors. Competition in the healthcare and real estate sectors is intense, with companies like AAPGV, AMEUF, CMXC, CNVCF, and COPHF vying for market share. China Medical & HealthCare Group Limited differentiates itself through its integrated approach, combining healthcare, eldercare, and property development.
Key Customers
- Patients seeking medical care at its hospitals.
- Elderly individuals and their families seeking eldercare services.
- Residents of its independent living units and health campuses.
- Borrowers seeking financial services.
- Investors in its securities trading and investments business.
Financials
Chart & Info
China Medical & HealthCare Group Limited (COLRF) stock price: Price data unavailable
Latest News
No recent news available for COLRF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for COLRF.
Price Targets
Wall Street price target analysis for COLRF.
MoonshotScore
What does this score mean?
The MoonshotScore rates COLRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Muk Yin Kong
CEO
Muk Yin Kong serves as the CEO of China Medical & HealthCare Group Limited, overseeing the company's diverse operations across healthcare, eldercare, property development, and financial services. His leadership guides the strategic direction of the company, focusing on expanding its presence in key markets and enhancing its service offerings. Prior to this role, Muk Yin Kong held various leadership positions in different sectors, bringing a wealth of experience to the company. His background includes expertise in finance, operations, and strategic management.
Track Record: Under Muk Yin Kong's leadership, China Medical & HealthCare Group Limited has focused on expanding its healthcare and eldercare services, particularly in response to the growing demand in China and other regions. Key milestones include the development of new health campuses and the implementation of advanced medical technologies. His strategic decisions have contributed to the company's growth and diversification.
COLRF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that China Medical & HealthCare Group Limited may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risks due to the potential for less transparency and liquidity compared to listed companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to lower trading volumes.
- Wider bid-ask spreads, increasing transaction costs.
- Potential for price volatility.
- Less stringent regulatory oversight compared to listed companies.
- Unknown disclosure status, making it difficult to assess the company's financial health.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Determine the company's regulatory compliance status.
- Assess the liquidity and trading volume of the stock.
- Understand the risks associated with investing in OTC stocks.
- Operations in multiple countries (China, Australia, Philippines).
- Diversified business segments (healthcare, eldercare, property development, financial services).
- Long operating history (incorporated in 1990).
- Dividend yield of 3.16%.
COLRF Healthcare Stock FAQ
What does China Medical & HealthCare Group Limited do?
China Medical & HealthCare Group Limited is an investment holding company that operates hospitals and eldercare facilities across China, Australia, and the Philippines. The company is also involved in property development, financial services, and securities trading. Its healthcare segment focuses on providing medical services, while its eldercare segment caters to the growing demand for elderly care facilities and services. The company's diversified business model allows it to capture value across different stages of the healthcare and real estate value chains.
What do analysts say about COLRF stock?
AI analysis is currently pending for China Medical & HealthCare Group Limited (COLRF). Therefore, a summary of analyst consensus, key valuation metrics, and growth considerations is not available at this time. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Further information will be available as the AI analysis is completed.
What are the main risks for COLRF?
China Medical & HealthCare Group Limited faces several risks, including intense competition from other healthcare providers and real estate developers. Changes in healthcare regulations and reimbursement policies could also negatively impact the company's profitability. Economic downturns could reduce demand for healthcare services and property, while fluctuations in currency exchange rates could affect its financial performance. As an OTC stock, COLRF also faces risks related to limited liquidity and price volatility.
What are the key factors to evaluate for COLRF?
China Medical & HealthCare Group Limited (COLRF) currently holds an AI score of 48/100, indicating low score. Key strength: Diversified operations across healthcare, eldercare, property development, and financial services.. Primary risk to monitor: Ongoing: Intense competition from other healthcare providers and real estate developers.. This is not financial advice.
How frequently does COLRF data refresh on this page?
COLRF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven COLRF's recent stock price performance?
Recent price movement in China Medical & HealthCare Group Limited (COLRF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified operations across healthcare, eldercare, property development, and financial services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider COLRF overvalued or undervalued right now?
Determining whether China Medical & HealthCare Group Limited (COLRF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying COLRF?
Before investing in China Medical & HealthCare Group Limited (COLRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending for analyst consensus.